GNRH1 and rheumatoid arthritis: The Antagonist to Gonadotropin-Releasing Hormone in Rheumatoid Arthritis (AGRA) study investigated the safety and efficacy of a GnRH-antagonist, cetrorelix (Cetrotide, Merck Serono), in RA [16].